# Oruka Therapeutics (ORKA) — Overview

ORKA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/orka

## Price

Last close $73.87 on Oct 15, 2026. 52-week range $26.19 – $113.08.

## Company profile

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$41.2M |
| Net income growth (year over year) | -67.68% |
| Net margin | 0.00% |
| Return on equity | -18.23% |
| EPS (trailing twelve months) | −$2.04 |
| Book value per share | $18.20 |
| P/E (trailing twelve months) | — |
| Price to book | 4.4 |
| Debt to assets | 2.18% |
| Payout ratio | -27.95% |
| Dividend yield | 0.85% |

## Frequently Asked Questions

### How do I buy stock in Oruka Therapeutics (ORKA)?

ORKA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).